Sabada Dube, PhD

Director of Epidemiology
Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca
Cambridge, England, United Kingdom

Sabada Dube PhD, is a director of epidemiology at AstraZeneca and is based in the UK. Trained as a infectious disease epidemiologists, Sabada has extensive experience in public health, clinical trials, academia, consultancy and biopharma. Currently, Sabada is leading global COVID-19 burden of illness evidence generation generation activities at AstraZeneca.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 1096 - Fully Vaccinated Individuals with Immunocompromised Conditions (IC) are Still at Increased Risk of Severe COVID-19 Outcomes From the Omicron Variant: Initial Results From INFORM, a Retrospective Health Database Observational Study in England

  Friday, October 13, 2023
  10:45 AM – 11:00 AM US ET

• 1095 - Increased Risk of COVID-19 Hospitalization and Death in Vaccinated Patients with End-Stage Renal Disease (ESRD) and Dialysis: Initial Results from INFORM, a Retrospective Health Database Observational Study in England

  Friday, October 13, 2023
  11:00 AM – 11:15 AM US ET